Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 1273789, 10 pages
https://doi.org/10.1155/2017/1273789
Research Article

Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences

1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
2Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK
3Centre of Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
4Department of Diabetes and Endocrinology, Derby Teaching Hospitals NHS Foundation Trust, Derby, UK

Correspondence should be addressed to Abd A. Tahrani; ten.shn@inarhat.dba

Received 21 November 2016; Revised 1 February 2017; Accepted 19 February 2017; Published 20 March 2017

Academic Editor: Patrizio Tatti

Copyright © 2017 Abd A. Tahrani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Vinik, T. S. Park, K. B. Stansberry, and G. L. Pittenger, “Diabetic neuropathies,” Diabetologia, vol. 43, no. 8, pp. 957–973, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Ziegler, K. Dannehl, H. Muhlen, M. Spuler, and F. A. Gries, “Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy,” Diabetic Medicine, vol. 9, no. 9, pp. 806–814, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. The DCCT Research Group, “Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT),” Diabetes, vol. 37, no. 4, pp. 476–481, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Toeller, A. E. Buyken, G. Heitkamp, G. Berg, and W. A. Scherbaum, “Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions,” Hormone and Metabolic Research, vol. 31, no. 12, pp. 680–685, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. R. E. Maser, A. R. Steenkiste, J. S. Dorman et al., “Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study,” Diabetes, vol. 38, no. 11, pp. 1456–1461, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. C. N. De Wytt, R. V. Jackson, G. I. Hockings, J. M. Joyner, and C. R. Strakosch, “Polyneuropathy in Australian outpatients with type II diabetes mellitus,” Journal of Diabetes and Its Complications, vol. 13, no. 2, pp. 74–78, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Stevens, F. Dayanikli, D. M. Raffel et al., “Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy,” Journal of the American College of Cardiology, vol. 31, no. 7, pp. 1575–1584, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Stevens, D. M. Raffel, K. C. Allman et al., “Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk,” Circulation, vol. 98, no. 10, pp. 961–968, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Partanen, L. Niskanen, J. Lehtinen, E. Mervaala, O. Siitonen, and M. Uusitupa, “Natural history of peripheral neuropathy in patients with non-insulin- dependent diabetes mellitus,” New England Journal of Medicine, vol. 333, no. 2, pp. 89–94, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Töyry, L. K. Niskanen, M. J. Mäntysaari, E. A. Länsimies, and M. I. J. Uusitupa, “Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis,” Diabetes, vol. 45, no. 3, pp. 308–315, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Google Scholar
  13. S. Tesfaye, N. Chaturvedi, S. E. M. Eaton et al., “Vascular risk factors and diabetic neuropathy,” New England Journal of Medicine, vol. 352, no. 4, pp. 341–431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Elliott, S. Tesfaye, N. Chaturvedi et al., “Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors,” Diabetes Care, vol. 32, no. 10, pp. 1896–1900, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Tahrani, T. Askwith, and M. J. Stevens, “Emerging drugs for diabetic neuropathy,” Expert Opinion on Emerging Drugs, vol. 15, no. 4, pp. 661–683, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Brownlee, “The pathobiology of diabetic complications,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Abbott, A. P. Garrow, A. L. Carrington, J. Morris, E. R. Van Ross, and A. J. Boulton, “Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the U.K.,” Diabetes Care, vol. 28, no. 8, pp. 1869–1875, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Abbott, N. Chaturvedi, R. A. Malik et al., “Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans,” Diabetes Care, vol. 33, no. 6, pp. 1325–1330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Chaturvedi, C. A. Abbott, A. Whalley, P. Widdows, S. Y. Leggetter, and A. J. M. Boulton, “Risk of diabetes-related amputation in South Asians vs. Europeans in the UK,” Diabetic Medicine, vol. 19, no. 2, pp. 99–104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. H. Barnett, A. N. Dixon, S. Bellary, M. W. Hanif, J. P. O'Hare, and N. T. Raymond, “Type 2 diabetes and cardiovascular risk in the UK south Asian community,” Diabetologia, vol. 49, no. 10, pp. 2234–2246, 2006. View at Google Scholar
  21. A. A. Tahrani, A. Ali, N. T. Raymond et al., “Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 5, pp. 434–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Tahrani, A. Ali, N. T. Raymond et al., “Obstructive sleep apnea and diabetic nephropathy: a cohort study,” Diabetes Care, vol. 36, no. 11, pp. 3718–3725, 2013. View at Publisher · View at Google Scholar
  23. A. A. Tahrani, K. Dubb, N. T. Raymond et al., “Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study,” Diabetologia, vol. 57, no. 6, pp. 1249–1256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. A. M. Tahrani, Microvascular complications in patients with type 2 diabetes: the impact of ethnicity, sleep and oxidative stress [Ph.D. thesis], University of Birmingham, 2013.
  25. E. L. Feldman, M. J. Stevens, P. K. Thomas, M. B. Brown, N. Canal, and D. A. Greene, “A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy,” Diabetes Care, vol. 17, no. 11, pp. 1281–1289, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. Epidemiology of Diabetes Interventions and Complications (EDIC), “Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort,” Diabetes Care, vol. 22, no. 1, pp. 99–111, 1999. View at Google Scholar
  27. C. L. Martin, J. Albers, W. H. Herman et al., “Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion,” Diabetes Care, vol. 29, no. 2, pp. 340–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Boyraz and M. Saracoglu, “The effect of obesity on the assessment of diabetic peripheral neuropathy: a comparison of Michigan patient version test and Michigan physical assessment,” Diabetes Research and Clinical Practice, vol. 90, no. 3, pp. 256–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Moghtaderi, A. Bakhshipour, and H. Rashidi, “Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy,” Clinical Neurology and Neurosurgery, vol. 108, no. 5, pp. 477–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Pambianco, T. Costacou, E. Strotmeyer, and T. J. Orchard, “The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort,” Diabetes Research and Clinical Practice, vol. 92, no. 2, pp. 280–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Colombo, W. C. M. Shoemaker, H. M. Belzberg, G. M. Hatzakis, P. M. Fathizadeh, and D. M. Demetriades, “Noninvasive monitoring of the autonomic nervous system and hemodynamics of patients with blunt and penetrating trauma,” Journal of Trauma—Injury, Infection & Critical Care, vol. 65, no. 6, pp. 1364–1373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Ziegler, G. Laux, K. Dannehl et al., “Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses,” Diabetic Medicine, vol. 9, no. 2, pp. 166–175, 1992. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Roustit, C. Millet, S. Blaise, B. Dufournet, and J. L. Cracowski, “Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity,” Microvascular Research, vol. 80, no. 3, pp. 505–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-L. Cracowski, C. T. Minson, M. Salvat-Melis, and J. R. Halliwill, “Methodological issues in the assessment of skin microvascular endothelial function in humans,” Trends in Pharmacological Sciences, vol. 27, no. 9, pp. 503–508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Pop-Busui, J. Lu, N. Lopes, and T. L. Z. Jones, “Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort,” Journal of the Peripheral Nervous System, vol. 14, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. A. Tahrani, A. Ball, L. Shepherd, A. Rahim, A. F. Jones, and A. Bates, “The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK,” International Journal of Clinical Practice, vol. 64, no. 3, pp. 351–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. T. D. Wiggin, K. A. Sullivan, R. Pop-Busui, A. Amato, A. A. F. Sima, and E. L. Feldman, “Elevated triglycerides correlate with progression of diabetic neuropathy,” Diabetes, vol. 58, no. 7, pp. 1634–1640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. A. H. Barnett, A. N. Dixon, S. Bellary et al., “Type 2 diabetes and cardiovascular risk in the UK south Asian community,” Diabetologia, vol. 49, no. 10, pp. 2234–2246, 2006. View at Google Scholar
  39. L. J. Gray, T. Yates, M. J. Davies et al., “Defining obesity cut-off points for migrant South Asians,” PLoS ONE, vol. 6, no. 10, Article ID e26464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Razak, S. S. Anand, H. Shannon et al., “Defining obesity cut points in a multiethnic population,” Circulation, vol. 115, no. 16, pp. 2111–2118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. R. Preis, J. M. Massaro, U. Hoffmann et al., “Neck circumference as a novel measure of cardiometabolic risk: the framingham heart study,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 8, pp. 3701–3710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Caffo, M. Diener-West, N. M. Punjabi, and J. Samet, “A novel approach to prediction of mild obstructive sleep disordered breathing in a population-based sample: the sleep heart health study,” Sleep, vol. 33, no. 12, pp. 1641–1648, 2010. View at Google Scholar · View at Scopus
  43. G. D. Foster, M. H. Sanders, R. Millman et al., “Obstructive sleep apnea among obese patients with type 2 diabetes,” Diabetes Care, vol. 32, no. 6, pp. 1017–1019, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Yim-Yeh, S. Rahangdale, A. T. D. Nguyen et al., “Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus,” Obesity, vol. 19, no. 1, pp. 17–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Dirani, J. Xie, E. Fenwick et al., “Are obesity and anthropometry risk factors for diabetic retinopathy?: the diabetes management project,” Investigative Ophthalmology and Visual Science, vol. 52, no. 7, pp. 4416–4421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Dandona, H. Ghanim, A. Chaudhuri, and P. Mohanty, “Thiazolidinediones—improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 22, no. 1, pp. 62–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. W. D. Strain, A. D. Hughes, J. Mayet et al., “Attenuation of microvascular function in those with cardiovascular disease is similar in patients of Indian Asian and European descent,” BMC Cardiovascular Disorders, vol. 10, no. 1, article 3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Misra and L. Khurana, “Obesity-related non-communicable diseases: South Asians vs White Caucasians,” International Journal of Obesity, vol. 35, no. 2, pp. 167–187, 2011. View at Publisher · View at Google Scholar · View at Scopus